Hbm Healthcare Investments Stock Debt To Equity
| HBMN Stock | CHF 175.60 5.80 3.20% |
HBM Healthcare Investments fundamentals help investors to digest information that contributes to HBM Healthcare's financial success or failures. It also enables traders to predict the movement of HBM Stock. The fundamental analysis module provides a way to measure HBM Healthcare's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to HBM Healthcare stock.
HBM |
HBM Healthcare Investments Company Debt To Equity Analysis
HBM Healthcare's Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Current HBM Healthcare Debt To Equity | 12.70 % |
Most of HBM Healthcare's fundamental indicators, such as Debt To Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, HBM Healthcare Investments is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
| Competition |
According to the company disclosure, HBM Healthcare Investments has a Debt To Equity of 12.7%. This is 76.28% lower than that of the Healthcare sector and 34.4% lower than that of the Biotechnology industry. The debt to equity for all Switzerland stocks is 73.92% higher than that of the company.
HBM Debt To Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses HBM Healthcare's direct or indirect competition against its Debt To Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of HBM Healthcare could also be used in its relative valuation, which is a method of valuing HBM Healthcare by comparing valuation metrics of similar companies.HBM Healthcare is currently under evaluation in debt to equity category among its peers.
HBM Fundamentals
| Return On Equity | -0.25 | |||
| Return On Asset | -0.14 | |||
| Operating Margin | 1.00 % | |||
| Current Valuation | 2.49 B | |||
| Shares Outstanding | 6.96 M | |||
| Shares Owned By Insiders | 16.89 % | |||
| Shares Owned By Institutions | 4.76 % | |||
| Price To Earning | 10.40 X | |||
| Price To Book | 0.78 X | |||
| Price To Sales | 4.28 X | |||
| Revenue | (76.5 M) | |||
| Gross Profit | (73.78 M) | |||
| EBITDA | (75.31 M) | |||
| Net Income | (78.03 M) | |||
| Cash And Equivalents | 5.39 M | |||
| Cash Per Share | 0.73 X | |||
| Total Debt | 148.92 M | |||
| Debt To Equity | 12.70 % | |||
| Current Ratio | 0.09 X | |||
| Book Value Per Share | 253.59 X | |||
| Cash Flow From Operations | (10.2 M) | |||
| Earnings Per Share | (11.22) X | |||
| Target Price | 301.0 | |||
| Beta | 0.78 | |||
| Market Capitalization | 1.48 B | |||
| Total Asset | 2.14 B | |||
| Z Score | 5.4 | |||
| Annual Yield | 0.05 % | |||
| Net Asset | 2.14 B | |||
| Last Dividend Paid | 9.7 |
About HBM Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze HBM Healthcare Investments's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of HBM Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of HBM Healthcare Investments based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for HBM Stock Analysis
When running HBM Healthcare's price analysis, check to measure HBM Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HBM Healthcare is operating at the current time. Most of HBM Healthcare's value examination focuses on studying past and present price action to predict the probability of HBM Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HBM Healthcare's price. Additionally, you may evaluate how the addition of HBM Healthcare to your portfolios can decrease your overall portfolio volatility.